The Deficiency of Serum Mannose Binding Lectin in Early Onset Idiopathic Pulmonary Fibrosis and Familial Cases

VA, Varney

doi:10.4172/2155-9899.1000127

Cited by 3 publications

(3 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The role of lectins in IPF is largely unknown. A previous study reported an association between MBL deficiency in serum and the development of IPF in young (<55 years) and familial cases of IPF, but not in older, typical IPF patients (12). The patients of our IPF cohort (mean age of 77) had rather elevated than deficient plasma MBL levels, thus confirming that MBL deficiency is probably not implicated in IPF.…”

Section: Discussionsupporting

confidence: 76%

See 1 more Smart Citation

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

et al. 2020

View full text Add to dashboard Cite

Complement in Interstitial Lung Diseases p = 0.44; BALF, 37.5 vs. 24.6 ng/ml, p = 0.7) as well as lower ficolin-2 plasma levels (plasma 1111 vs. 1647 ng/ml, p = 0.11). Ficolin-2 plasma levels were inversely correlated with the forced vital capacity (r = 0.55, p = 0.1). Conclusion: This is the first study to simultaneously assess systemic and local lectin pathway protein levels in ILD patients. Our data suggest an involvement of PRR of the lectin pathway in the pathogenesis of sarcoidosis given the significantly higher BALF levels compared to a control group. Additional analyses in a larger patient cohort are required to confirm or refute a potential effect of local and/or systemic ficolin-2 levels in IPF patients.

show abstract

Section: Discussionsupporting

confidence: 76%

“…In the context of ILD, some evidence points to a relevant involvement of the lectin pathway. A case control study found a link between MBL deficiency and early onset IPF and familial cases (12). Similarly, MBL deficiency was associated with coal workers' pneumoconiosis, implying an important role of MBL in pulmonary host defense (13).…”

Section: Introductionmentioning

confidence: 99%

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

et al. 2020

View full text Add to dashboard Cite

show abstract

“…94 In addition, a case control study described the occurrence of MBL deficiency in early onset IPF and familial cases. 95 The possible involvement of the LP in the pathogenesis of ILD has been suggested by evidence reporting the significantly higher level of CS products in the bronchoalveolar lavage fluid (BALF) in a cohort of patients with ILD compared with controls. 96 Authors hypothesized that, in SSc-ILD, the recurrent injuries, which recognized a lectin-mediated ischemic-reperfusion mechanism, might cause an endothelial dysfunction potentially leading to endothelial and epithelial apoptosis and the fibrotic response in the lung.…”

Section: Dovepressmentioning

confidence: 99%

Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease

Triggianese¹,

Conigliaro²,

Martino³

et al. 2023

OARRR

View full text Add to dashboard Cite

Complement system (CS) dysregulation is a key factor in the pathogenesis of different autoimmune diseases playing a central role in many immune innate and adaptive processes. Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by ta breach of selftolerance leading to a synovitis and extra-articular manifestations. The CS is activated in RA and seems not only to mediate direct tissue damage but also play a role in the initiation of RA pathogenetic mechanisms through interactions with citrullinated proteins. Interstitial lung disease (ILD) represents the most common extra-articular manifestation that can lead to progressive fibrosis. In this review, we focused on the evidence of CS dysregulation in RA and in ILD, and highlighted the role of the CS in both the innate and adaptive immune responses in the development of diseases, by using idiopathic pulmonary fibrosis as a model of lung disease. As a proof of concept, we dissected the evidence that several treatments used to treat RA and ILD such as glucocorticoids, pirfenidone, disease modifying antirheumatic drugs, targeted biologics such as tumor necrosis factor (TNF)-inhibitors, rituximab, tocilizumab, and nintedanib may act indirectly on the CS, suggesting that the CS might represent a potential therapeutic target in these complex diseases.

show abstract

Deficiency of Mannose Associated Serine Protease2 (MASP2) in Patients with Idiopathic Pulmonary Fibrosis

VA¹,

Parnell²

2015

J Clin Cell Immunol

View full text Add to dashboard Cite

Background: Idiopathic pulmonary fibrosis (UIP/IPF) is increasing. The condition occurs both sporadically and in close blood relatives suggesting a genetic predisposition. Histology suggests that the fibrosis is linked to disordered apoptosis, but the causal agent is so far unrecognised. We previously published evidence of mannose binding lectin deficiency (MBL) in early onset disease and in those with a family history of UIP/IPF. MBL is part of the innate immune system with levels genetically determined. MBL activation is impaired if the mannose associated serine protease2 (MASP-2) is severely deficient in the serum (levels<100 ng/ml). The MBL/MASP-2 complex is involved in phagocytosis, complement activation and clearance of apoptotic cells. Levels of MASP-2 are genetically determined and not influenced by inflammation. Aims and Method: We examined plasma MASP-2 levels in healthy controls (HC) and in patients with frequently exacerbating COPD, pulmonary TB and sarcoid along with UIP/IPF including those with or without a family history. Results: Mean serum MASP-2 levels were lowest in those with UIP/IPF (304 ng/ml) compared with healthy controls (537 ng/ml), COPD (1090 ng/ml), TB (659 ng/ml) and sarcoid (385 ng/ml). Chi square analysis for the frequency of severe MASP-2 deficiency (<100 ng/ml versus >100 ng/ml) showed no differences between Healthy Controls, COPD, TB and sarcoid. UIP/IPF showed a significant increase in the frequency of severe deficiency. This was seen for early onset disease<55yrs (33% p=0.0001), late onset>55yrs (20% p=0.0001) and those with a family history (19% p=0.0143). The expected frequency for the Caucasian population is <1%. Conclusion: The data shows that severe MASP-2 deficiency is seen in our UIP/IPF patients and is highest in those with early onset disease. For TB and Sarcoid there is an increased frequency of deficiency (6-7%) compared with healthy controls (3%): and these diseases can also give fibrotic scarring to the lung. Since MASP-2 levels<100 ng/ml are considered to cause impaired function of the lectin pathway it could have relevance to complement activation, apoptosis and fibrosis in this disease.

show abstract

The Deficiency of Serum Mannose Binding Lectin in Early Onset Idiopathic Pulmonary Fibrosis and Familial Cases

Cited by 3 publications

References 46 publications

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease

Deficiency of Mannose Associated Serine Protease2 (MASP2) in Patients with Idiopathic Pulmonary Fibrosis

Contact Info

Product

Resources

About